Drug Shortage Report for MAR-MONTELUKAST

Last updated on 2020-01-09 History
Report ID 852
Drug Identification Number 02399997
Brand name MAR-MONTELUKAST
Common or Proper name MAR-Montelukast
Company Name MARCAN PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 Tablet
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-11-10
Actual start date 2019-11-10
Estimated end date 2020-01-08
Actual end date 2020-01-08
Shortage status Resolved
Updated date 2020-01-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2 GURDWARA RD., SUITE 112
OTTAWA, ONTARIO
CANADA K2E 1A2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2020-01-09 English Compare
v19 2020-01-08 French Compare
v18 2020-01-08 English Compare
v17 2020-01-08 French Compare
v16 2020-01-08 English Compare
v15 2018-07-06 French Compare
v14 2018-07-06 English Compare
v13 2018-07-05 French Compare
v12 2018-07-05 English Compare
v11 2018-06-29 French Compare
v10 2018-06-29 English Compare
v9 2018-04-02 French Compare
v8 2018-04-02 English Compare
v7 2017-11-23 French Compare
v6 2017-11-23 English Compare
v5 2017-11-23 French Compare
v4 2017-11-23 English Compare
v3 2017-03-14 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 20 of 20